Equitable Holdings Inc. Purchases New Position in Corteva, Inc. $CTVA

Equitable Holdings Inc. acquired a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 17,547 shares of the company’s stock, valued at approximately $1,486,000.

Other institutional investors have also recently made changes to their positions in the company. EFG International AG purchased a new stake in Corteva during the second quarter worth $25,000. Compass Financial Management LLC purchased a new stake in shares of Corteva during the 2nd quarter worth about $25,000. Elevation Wealth Partners LLC grew its position in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after acquiring an additional 261 shares during the period. Clearstead Trust LLC purchased a new position in shares of Corteva in the 2nd quarter valued at about $31,000. Finally, JPL Wealth Management LLC acquired a new position in Corteva in the 3rd quarter worth about $25,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Price Performance

Shares of NYSE CTVA opened at $84.00 on Friday. The firm has a 50-day simple moving average of $82.69 and a 200-day simple moving average of $80.54. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $56.04 billion, a price-to-earnings ratio of 55.63, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the prior year, the company earned $2.20 EPS. Corteva’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is currently 47.68%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. UBS Group cut their price objective on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday, August 18th. BNP Paribas Exane boosted their price target on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, Citigroup lifted their price objective on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.